European Archives - Page 466 of 1206 - European Medical Journal

Introducing Mavacamten for the Treatment of NYHA Class II and III Symptomatic Obstructive HCM in Adult Patients

This infographic explores mavacamten, the first cardiac myosin inhibitor for New York Heart Association (NYHA) Class II and III…

Live Webinar: Translating Science into Patient Care: How are we treating muscle invasive bladder cancer patients today? October 10th 3:00 PM - 4:30 PM BST

This webinar will explore current treatment options for patients with muscle-invasive urothelial carcinoma.

Preventive Medicine in Gastroenterology

Presenting how a preventive approach should look for colorectal cancer, inflammatory bowel disease, and gastrointestinal cancer…

Disparities in Survival Outcomes Following Second Primary Cancer Diagnosis

New research shows racial disparities in cancer-related deaths. The risk of cancer-related death is increased for Black and Hispanic patients following diagnosis of a second primary cancer compared with cancer-related death risk for White patients.

Sensitivity And Specificity of FEF25–75/Forced Vital Capacity for Diagnosing Restrictive Lung Disease

There are two major categories of lung functional disorders, including restrictive and obstructive lung diseases. Restrictive lung disease…

A Link Between Sugary Drinks and Liver Cancer Risk?

Post-menopausal females who drink who drink ≥1 sugar-sweetened drink per day could have a greater risk for liver cancer and chronic liver disease mortality, according to new research.

Sickle Cell Spotlight: Advancements in Treatment and Care

Sophie Lanzkron joins Jonathan to discuss advancements in the treatment of sickle cell disease and how this affects quality of life.

Standard of Care for the Treatment of Endometrial Cancer: Change Is Afoot

Explore this infographic for insight on the current National Comprehensive Cancer Network (NCCN) guidelines on the standard of care…

Catching the ever elusive insight

How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?

Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease

This article was funded by Sanofi and is intended for healthcare professionals.